1. Introduction {#sec1}
===============

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. There are two principal forms of this disorder: the inability of the pancreas to produce insulin (type 1) and the inability of the body to properly respond to the action of insulin produced (type 2) ([@bib31]). Over the past three decades, diabetes prevalence has been increasing more rapidly. In 2017, approximately 451 million people worldwide had diabetes mellitus, and this number is expected to rise to 693 million by 2045 ([@bib6]). From this number, 90%--95% of the cases are type 2 or non-insulin-dependent diabetes ([@bib1]), which, if uncontrolled, will lead to many severe complications ([@bib10]). Thailand is among Asian countries with high prevalence of diabetes ([@bib20]). With over 4.2 million cases of diabetes, this disorder is increasingly becoming a major cause of death and the main public health problem in Thailand ([@bib25]).

Although medications to improve glycemic levels are available, patients must spend high cost for the treatment of illness ([@bib3]), and all antidiabetic agents have adverse effects, such as gastrointestinal and cardiovascular adverse effects, infection of the upper respiratory tract, weight gain, and increased risk of bone fracture ([@bib17]). Moreover, drug therapy of diabetes includes not only hypoglycemic agents but also strategies to maintain glycemic control over time, which often requires several drugs with different mechanisms of action ([@bib8]). Accordingly, screening and development of compounds for effective, safe, and well-tolerated treatment of diabetes are still necessary.

Presently, the Thai government has developed a strategy to promote physical activity and balanced diet using traditional herbs to enhance the health of diabetes patients, which has been accepted as a regulation in the public health system ([@bib34]). However, more than a hundred plants used for diabetes treatment in regional healing practices have been subjected to minimal or no industrial development. The information of their chemical profile and pharmacological properties which are necessary for the development of new antidiabetic compounds ([@bib11]) is still lacking, and desire to perform the public credible in their use is constantly strengthened ([@bib19]).

*Garcinia cowa* Roxb. ex Choisy (Clusiaceae), commonly known as ''Cha muang'' in Thailand, is a Thai local edible plant used for treating diabetes patients. This plant has medium-sized tree and is distributed in undulating areas and evergreen forests in tropical and subtropical countries ([@bib24]). The young leaves of *G. cowa* are used as vegetables and some parts of the plant have been used in the folk medicine for various purposes. The bark has been used as an antipyretic and antimicrobial agent ([@bib15]), while the fruits and leaves are used for the improvement of blood circulation, as an expectorant for the treatment of coughs and indigestion and as a laxative ([@bib26]). The latex and the root have been used for fever relief ([@bib21]) and the bark has been used as an antipyresis agent in Thai folk medicine ([@bib21]). Some biological activities of the leaf extract have been reported for antitumor-promoting and inflammation activities ([@bib15]). The chemical constituents of this plant are xanthones and benzophenones ([@bib33]), which are found in various parts of the plants; these substances have shown anticancer ([@bib38]), anti-inflammatory ([@bib36], [@bib37]), antioxidant ([@bib23]), antibacterial ([@bib29]), and *α*-glucosidase inhibitory ([@bib33]) effects. However, literatures on the investigation of the leaves of this plant are still scarce. Recently, we reported the isolation of two new phloroglucinol benzophenones and three new xanthones from the fresh leaves of *G. cowa* and their nitric oxide production and α-glucosidase inhibitory activities ([@bib41]). To continue the chemical study of this plant but different in the plant varieties and the place of collection, the aim of this study is to discover and identify bioactive compounds related to anti-diabetic properties from the ethyl acetate extract of *G. cowa* leaves (GCEA). We report herein the bioassay-guided isolation ([Figure 1](#fig1){ref-type="fig"}) and identification of antidiabetic compounds from *G. cowa* leaf extract, collected from Tasud Subdistrict, Chiang Rai Province, Thailand.Figure 1Bioassay-guided isolation of *G.cowa* leaf extract.Figure 1

2. Results {#sec2}
==========

2.1. Antidiabetic property of the ethyl acetate extract of the leaves of *G. cowa* (GCEA) {#sec2.1}
-----------------------------------------------------------------------------------------

Previous studies had been reported the subacute toxicity of ethyl acetate extract of *G. cowa* in mice. The extract did not exert any toxicity nor cause mortality during a 21-day study ([@bib37]). For safety analysis, in present study, the antidiabetic potential of GCEA was evaluated using α-glucosidase inhibitory, glucose uptake, and glucose consumption assays, and the results are presented in [Table 1](#tbl1){ref-type="table"}. In the α-glucosidase assay, the extract showed an IC50 value of 21.4 μg/mL, which was greater than that of the standard drug (acarbose). Similarly, the results of the glucose consumption and glucose uptake assays also showed that the GCEA induced glucose uptake by cells. GCEA at 100 μg/mL led to the highest cellular glucose uptake of 1.7-fold ([Figure 2](#fig2){ref-type="fig"}A) under immuncyto fluorescence image (20×) of glucose uptake expression ([Figure 2](#fig2){ref-type="fig"}B) compared with that in the control. The extract increased glucose consumption by 3T3-L1 cells with IC~50~ value of 39.8 μg/mL. Thus, GCEA may contain active compounds that exert pharmacologic effects.Table 1α-Glucosidase inhibition, glucose consumption, and glucose uptake activities of *G. cowa* leaf extract (GCEA).Table 1Sample*α*-glucosidase inhibition (IC~50~, μg/mL)glucose consumption (IC~50~, μg/mL)glucose uptake (fold induction)GCEA21.439.81.7Acarbose60.4NTNTMetforminNT6.33.8Figure 2Effects of GCEA on glucose uptake in L6 muscle cells. (A) Scale bar of glucose uptake in differentiated L6 myotube. (B) Immuncyto fluorescence image (20×) measured expression of glucose uptake in differentiated L6 myoblast.Figure 2

2.2. *α*-Glucosidase inhibitory activity-guided fractionation of the leaf extract of *G. cowa* {#sec2.2}
----------------------------------------------------------------------------------------------

Bioassay-guided fractionation is used to connect drug discovery screening with biological response-linked instrumental analysis, and it can be performed in many stages to produce different results (Weller, 2012). In this study, GCEA was shown to exert potent inhibitory effect on α-glucosidase (inhibition rate = 99.3 ± 0.84% at a final concentration of 200 μg/mL), and its fractions, GC1-GC6, also showed strong α-glucosidase inhibitory activity (inhibition rate = 74.8--99.9%) ([Table 2](#tbl2){ref-type="table"}).These findings suggested that some compounds of these subfractions may act in synergy on a single or multiple target sites ([@bib35]).Table 2α-Glucosidase inhibitory activity of crude extract and fractions at 200 μg/mL.Table 2crude extract/fraction% inhibition at 200 μg/mLGCEA99.3 ± 0.84%GC199.0 ± 0.46%GC290.4 ± 0.73%GC1-293.5 ± 0.90%GC1-2A79.5 ± 0.71%GC1-2B90.8 ± 0.85%GC1-2C29.2 ± 1.05%GC389.0 ± 0.97%GC488.7 ± 1.12%GC4A74.8 ± 0.92%GC599.0 ± 0.94%GC5A84.6 ± 0.70%GC5B35.1 ± 0.81%GC699.9 ± 0.74%GC6A96.6 ± 1.14%GC6B42.5 ± 0.59%GC6C19.7 ± 0.42%Acarbose98.9%

2.3. Structures of the isolated compounds {#sec2.3}
-----------------------------------------

Active fractions of GCEA were obtained using α-glucosidase inhibitory activity-guided fractionation and 11 compounds (**1--11**) were isolated from the subfractions, as shown in [Figure 3](#fig3){ref-type="fig"}. Most compounds were xanthones and benzophenones, which are widely found in plants of the *Garcinia* genus ([@bib27]). The structures of the isolated compounds were elucidated by spectroscopic data, and a novel compound, garciniacowone K (**1**), was discovered together with 10 known compounds. The spectroscopic data of the known compounds were compared with those reported and they were identified as guttiferone I (**2**) ([@bib18]), 1,7-dihydroxyxanthone (**3**) ([@bib16]), 1-hydroxyl-7 methoxyxanthone (**4**) ([@bib7]), mangostinone (**5**) ([@bib28]), α-mangostin (**6**) ([@bib22]), cowanol (**7**) ([@bib21]), gacibiphenyl C (**8**) ([@bib4]), friedelin (**9**) (Ho et al., 1995), β-friedelinol (**10**) ([@bib32]), and oleanane-12-ol (**11**) ([@bib2]). It should be noted that compounds isolated in this work, except for α-mangostin (**6**), were totally different from our previously study (Raksat et al., 2020).Figure 3Structures of compounds isolated from *G. cowa* leaves.Figure 3

3. Discussion {#sec3}
=============

3.1. Structure elucidation of a novel compound {#sec3.1}
----------------------------------------------

Garciniacowone K (**1**) was obtained as a white needle solid. Its HRESITOFMS data showed an \[M+Na\]^+^ ion at *m*/*z* 567.3814, implying a molecular formula of C~37~H~52~O~3~. The IR spectrum showed the presence of two carbonyl groups at 1708 (non-conjugated carbonyl group) and 1658 (conjugated carbonyl group) cm^−1^, respectively, and the UV spectrum showed maxima absorption band at λ~max~ at 249 and 300 nm. Intensive analysis of the ^1^H, ^13^C, DEPT, and 2D NMR spectroscopic data of **1** ([Table 3](#tbl3){ref-type="table"} and Supplementary Material) suggested that the core structure of this compound was a decahydro-1H-xanthene, which were deduced from the following NMR spectroscopic data: δ~H~/δ~C~ 1.53 (1H, br d, J = 9.7 Hz, H-2)/36.8, 1.54 (1H, m, H-3a) and 1.99 (1H, m, H-3b)/35.0, 1.20 (1H, m, H-7)/50.4, 1.32 (1H, m, 9a) and 1.12 (1H, m, 9b)/41.2, 1.81 (2H, m, H-10)/23.5, 1.30 (1H, m, 11a) and 1.29 ((1H, m, 11b)/39.6, 2.23 (1H, m, 12a) and 1.44 (1H, m, 12b)/31.2, δ~C~ 42.4 (C-1), 55.1 (C-4), 149.6 (C-5), 80.7 (C-6), 33.5 (C-8), and 130.1 (C-13). The ^1^H and ^13^C NMR resonances ([Table 3](#tbl3){ref-type="table"}) also displayed the characteristic resonances of a benzoyl unit \[δ~H~/δ~C~ 8.14 (2H, d, J = 6.8 Hz, H-16/H-20)/129.9, 7.44 (1H, m, H-18)/132.2, 7.40 (2H, m, H-17/H-19)/128.0, δ~C~ 200.5 (C-14), and 139.1 (C-15)\], a 3-methylbut-2-en-1-yl unit \[δ~H~/δ~C~ 5.01 (1H, m, H-28)/123.2, 2.01 (1H, m, H-27a) and 1.66 (1H, m, H-27b)/27.1, 1.61 (3H, s, H-30)/18.1, 1.71 (3H, s, H-31)/26.0, and δ~C~ 133.2 (C-29)\], a 4-methylpent-3-en-1-yl unit \[δ~H~/δ~C~ 1.33 (1H, m, H-32a) and 1.17 (1H, m, H-32b)/19.9, 1.81 (1H, m, H-33a) and 1.15 (1H, m, H-33b)/36.7, 4.39 (1H, t, J = 6.5 Hz, H-34)/124.3, 1.44 (3H, s, H-36)/25.7, 1.25 (3H, s, H-37)/17.4, and δ~C~ 130.9 (C-35)\], four methyl groups \[δ~H~/δ~C~ 1.06 (3H, s, H-21)/19.8, 0.71 (3H, s, H-22)/20.7, 0.86 (3H, s, H-23)/31.8, and 1.22 (3H, s, H-26)/23.2 \], and one acetyl group \[δ~H~/δ~C~ 2.33 (3H, s, H-25)/26.3 and δ~C~ 211.7 (C-24)\]. The ^1^H--^1^H COSY cross peaks of H-2/H~2~-3/H~2~-27/H-28 and HMBC correlations of H~2~-27 with C-1 (δ~C~ 42.4), C-2 (δ~C~ 36.8), and C-3 (δ~C~ 35.0) confirmed the location of the 3-methylbut-2-en-1-yl unit moiety at C-2. The 4-methylpent-3-en-1-yl unit was placed on C-1 due to the HMBC correlation of H~2~-32 with C-1, C-2, and C-13 (δ~C~ 130.1). Four methyl groups were assigned to CH~3~-21, CH~3~-22, CH~3~-23, and CH~3~-26, respectively, because of their HMBC correlations as shown in [Table 1](#tbl1){ref-type="table"} and [Figure 4](#fig4){ref-type="fig"}A. The key HMBC correlations ([Figure 4](#fig4){ref-type="fig"}A) between H~3~-25 and C-4 (δ~C~ 55.1) indicated that an acetyl unit was located at C-4 and the benzoyl unit was placed at C-13 by the process of elimination. The relative configuration of compound **1** was assigned by NOESY experiments. The NOESY cross-peaks ([Figure 4](#fig4){ref-type="fig"}B) of H~3~-26/H-3b/H~3~-25, H~3~-25/H-12b/H~3~-21 and H~3~-21/H-22/H-10b suggesting these protons were β-orientations and the ring junction of B/C ring was trans-orientation. Therefore, garciniacowone K was characterized as **1**.Table 3^1^H (500 MHz),^13^C (125 MHz), and HMBC NMR spectroscopic data of compound **1** in CDCl~3~.Table 3position*δ*~*C*~carbon type*δ*~*H*~ (*J* in Hz)HMBC (^1^H →^13^C)142.4C\--236.8CH1.53 (*br d*, 9.7)335.0CH~2~1.54, 1.99 (*m*)C-1, C-2, C-4, C-5, C-24455.1C\--5149.6C\--680.7C\--750.4CH1.20 (*m*)C-6, C-9, C-8, C-11, C-12833.5C-941.2CH~2~1.32, 1.12 (*m*)-1023.5CH~2~1.81 (*m*)-1139.6CH~2~1.30, 1.29 (*m*)C-91231.2CH~2~2.23, 1.44 (*m*)C-4, C-5, C-6, C-7, C-2413130.1C\--14200.5C\--15139.1C\--16129.9CH8.14 (*d*, 6.8)C-14, C-18, C-2017128.0CH7.40 (*m*)C-15, C-1918132.2CH7.44 (*m*)C-16, C-2019128.0CH7.40 (*m*)C-15, C-1720129.9CH8.14 (*d*, 6.8)C-14, C-16, C-182119.8CH~3~1.06 (*s*)C-6, C-7, C-112220.7CH~3~0.71 (*s*)C-7, C-8, C-9, C-232331.8CH~3~0.86 (*s*)C-7, C-8, C-2224211.7C\--2526.3CH~3~2.33 (*s*)C-4, C-242623.2CH~3~1.22 (*s*)C-1, C-2, C-132727.1CH~2~2.01, 1.66 (*m*)C-1, C-2, C-4, C-28, C-2928123.2CH5.01 (*m*)C-30, C-3129133.2C\--3018.1CH~3~1.61 (*s*)C-28, C-29, C-313126.0CH~3~1.71 (*s*)C-28, C-29, C-303219.9CH~2~1.33, 1.17 (*m*)C-1, C-133336.7CH~2~1.81, 1.15 (*m*)C-1, C-34, C-3534124.3CH4.39 (*t,* 6.5)C-36, C-3735130.9C\--3625.7CH~3~1.44 (*s*)C-34, C-35, C-373717.4CH~3~1.25 (*s*)C-34, C-35, C-36Figure 4Key correlations of compound **1**. (A) ^1^H--^1^H COSY and HMBC correlations. (B) NOESY correlations.Figure 4

3.2. α-Glucosidase inhibitory effect of the isolated compounds {#sec3.2}
--------------------------------------------------------------

Many compounds from the *Garcinia* genus have antidiabetic properties, according to in vitro studies ([@bib9]). The compounds isolated from *G. cowa* leaves (compounds **1--11**) and the standard drug acarbose at various concentrations were screened for α-glucosidase inhibitory activity. All samples exhibited a dose-dependent inhibitory effect. The IC~50~ values are presented in [Table 4](#tbl4){ref-type="table"}. The highest α-glucosidase inhibitory activity was shown by compound **2**, with IC~50~ value of 13.1 μM, followed by compound **6** (IC~50~ = 15.0 μM) and compound **7** (IC~50~ value = 18.0 μM). The positive control (acarbose) showed IC~50~ value of 93.3 μM α-Glucosidase enzyme plays an important role in carbohydrate digestion and absorption by catalyzing the conversion of polysaccharides into monosaccharides. Compounds **2**, **6**, and **7** are the main compound with higher α-glucosidase-inhibitory activity than that of acarbose (the positive control). This finding suggested that these compounds may have antidiabetic efficacy and may be further developed as a drug supplement following additional investigation of their activities and safety ([@bib13]).Table 4α-Glucosidase inhibitory and glucose consumption activities of compounds **1--11**.Table 4compound*α*-glucosidase inhibition (IC~50~, μM)glucose consumption (IC~50~, μM)% cell viability**1**\>100[a](#tbl4fna){ref-type="table-fn"}5.197.0**2**13.10.598.7**3**\>100[a](#tbl4fna){ref-type="table-fn"}56.9105.3**4**\>100[a](#tbl4fna){ref-type="table-fn"}23.2101.7**5**\>100[a](#tbl4fna){ref-type="table-fn"}16.093.1**6**15.04.8101.3**7**18.013.7100.9**8**NA34.796.6**9**\>100[a](#tbl4fna){ref-type="table-fn"}18.5101.0**10**NA25.3101.8**11**\>100[a](#tbl4fna){ref-type="table-fn"}13.5100.8Acarbose93.3NTNTMetforminNT45.499.7[^1]

3.3. Cytotoxicity of the isolated compounds and their effect on glucose consumption by 3T3-L1 cells {#sec3.3}
---------------------------------------------------------------------------------------------------

Glucose consumption is assessed by measuring the concentration of the compounds that can induce glucose uptake into cells ([@bib39]). As shown in [Table 4](#tbl4){ref-type="table"}, compared with the positive control, all samples at low concentration induced glucose uptake by 3T3-L1 cells without causing toxicity. Compound **2** showed the highest efficiency, with IC~50~ value of 0.5 μM. However, the other compounds also highly induced glucose consumption by 3T3-L1 cells, compared with the positive control (metformin).

4. Conclusions {#sec4}
==============

This was the first report of bioassay-guided isolation antidiabetic compounds from the EtOAc extract of the leaves of *G. cowa* and their effects on glucose consumption by 3T3-L1 cells and α-glucosidase activity. Investigation of active fractions through bioassay-guided isolation obtained a novel decahydro-1H-xanthene derivative along with 10 known compounds. Guttiferone I showed the highest efficacy inhibiting α-glucosidase enzyme and induced glucose consumption by 3T3-L1 cells without causing toxic effects with IC~50~ values of 13.1 and 0.5 μM, respectively. Our findings indicated that these bioactive compounds may be developed as a supplement for antidiabetic drugs.

5. Material and methods {#sec5}
=======================

5.1. General experimental instruments and chemical reagents {#sec5.1}
-----------------------------------------------------------

NMR spectra were recorded using an AVANCE NEO 500 and 400 MHz Bruker spectrometer (Bruker, Germany) in acetone-d~6~ and chloroform-d, with tetramethylsilane (Cambridge Isotope Laboratory, Inc, USA) as an internal standard. High resolution mass spectra were obtained on a Bruker microTOF mass spectrometer (Bruker, Germany). The quick-column chromatography (QCC) system consisted of silica gel C60 (0--20 mm; SiliCycle® Inc., Canada) and silica gel G60 (60--200 mm; SiliCycle® Inc.). Sephadex LH-20 was used for column chromatography (CC). Waters 10 g Sep-Pak\'s (RP-18, US) was used for reversed-phase flash chromatography. Thin-layer chromatography (TLC) was performed using silica gel GF~254~ plates (Merck, USA). A multimode microplate reader (Bio Tek, Vermont, USA) was used for measuring and recording absorbance. α-Glucosidase from *Saccharomyces cerevisiae* and 4-nitrophenyl-α-D-glucopyranoside (p-NPG) were purchased from Sigma Chemical Co. (St Louis, USA). 3T3-L1 and L6 myotube cells were purchased from the American Type Culture Collection (USA).

5.2. Plant material {#sec5.2}
-------------------

The leaves of *G.* *cowa* (Clusiaceae) were collected from Tasud, Muang, Chiang Rai Province, Thailand (GPS coordinates: 20.0449° N, 99.8943° E). The plant was authenticated by Assoc. Prof. Dr. Nijsiri Ruangrungsi, a botany specialist. A voucher specimen (MFU-NPR0186) was deposited at the Natural Products Research Laboratory, School of Science, Mae Fah Luang University.

5.3. Extraction and purification by bioassay-guided isolation {#sec5.3}
-------------------------------------------------------------

*G. cowa* leaves were extracted by maceration. Briefly, dried and pulverized plant materials (1.7 kg) were extracted with EtOAc (3 × 5 L, for 3 days) at room temperature (25 °C). Removal of the solvent under reduced pressure provided EtOAc extract (GCEA, 465.74 g, 27.36% w/w). A portion of GCEA (200.5 g) was subjected to QCC using silica gel eluting with a gradient of hexanes-EtOAc (100:0 to 0:100), yielding seven major fractions (GC1-GC7) based on TLC analysis. All fractions were prepared for α-glucosidase inhibitory assay, and active fractions were further isolated. Fractions GC1 and GC2 were combined (GC1-2, 20.35 g) and was subjected to QCC with silica gel eluting with a gradient of hexanes-EtOAc (100:0 to 0:100) to obtain three fractions (GC1-2A, GC1-2B, and GC1-2C). Fraction GC1-2A (3.27 g) was purified by CC on silica gel using hexanes-EtOAc (1:9) to obtain compounds **9** (8.1 mg), **10** (11.4 mg), and **11** (8.9 mg). Compound **1** (8.9 mg) was obtained from fraction GC1-2B (97.3 mg) by washing with hexanes. Fraction GC3 (3.70 g) was subjected to CC on silica gel using EtOAc-hexanes (1:9) to obtain compound **2** (6.2 mg). Fraction GC4 (6.32 g) was isolated by CC on Sephadex LH-20 using 100% MeOH, yielding compound **3** (13.8 mg) and fraction GC4-A (2.13 g), which was further subjected to CC on silica gel using EtOAc-hexanes (2:8) to obtain compound **8** (1.4 mg). Another active fraction, GC5 (11.54 g), was isolated by reversed-phase chromatography (RP-18; the eluent was MeOH--H~2~O (4:5) to obtain two fractions (GC5-A and GC5-B). Fraction GC5-A (1.76 g) was further subjected to CC on Sephadex LH-20 using 100% MeOH to obtain compound **4** (1.5 mg). Fraction GC6 (98.66 g) was subjected to QCC with hexanes-EtOAc (100:0 to 0:100), yielding three fractions (GC6A-GC6C). Fraction GC6A (3.45 g) was further subjected to CC on Sephadex LH-20 using 100% MeOH to give compounds **5** (3.8 mg), **6** (6.1 mg), and **7** (4.2 mg). The summary of bioassay-guided isolation was shown in [Figure 1](#fig1){ref-type="fig"}.

Garciniacowone K (**1**): white needle solid; mp 161--162 °C; \[α\]^23^~D~ +29 (c 0.1; CHCl~3~); UV (CHCl~3~) λ~max~ (log ε): 249 (2.77), 300 (2.69) nm; IR (KBr) υ~max~: 2961, 1708, 1658, 1455 cm^−1^; ^1^H and ^13^C-NMR spectral data, see [Table 3](#tbl3){ref-type="table"}; HRESITOFMS m/z 545.3992, \[M + H\]^+^ (calcd for C~37~H~53~O~3~, 545.3989).

5.4. Structure characterization {#sec5.4}
-------------------------------

The structures of the isolated compounds were characterized by spectroscopic methods, and ^1^H (500 MHz and 400 MHz) and ^13^C NMR spectral data were used for comparison with previously reported physical property and NMR spectroscopic data. In addition, the complicated structure was confirmed with 2D NMR data, including COSY, HSQC, HMBC, DEPT-135, and DEPT-90. The results were matched with mass spectral data.

5.5. α-Glucosidase inhibitory assay {#sec5.5}
-----------------------------------

The α-glucosidase inhibitory assay procedure followed a previously described method ([@bib14]) with modifications. Briefly, sample solutions at different concentrations (0.1--1000 μg/mL) were dissolved with 5% dimethyl sulfoxide (DMSO) in phosphate buffer (pH 6.8), and then 50 μL of each sample was pipetted and mixed with 50 μL of α-glucosidase enzyme (0.35 U/mL) in a 96-well micro plate. After preincubation at 37 °C for 10 min, 50 μL of 1.5 mM p-NPG was added, and the samples were further incubated at 37 °C for 20 min. Next, 100 μL of Na~2~CO~3~ (1 M) was added to terminate the reaction. Acarbose was used as a positive control. The absorbance was measured at 405 nm with a micro plate reader (PerkinElmer, Inc., USA). The process was repeated in triplicate, and the percent inhibition was calculated with the following equation:where,A is the absorbance of blank reaction containing only 5% DMSO in phosphate buffer,B is the absorbance of control reaction containing 5% DMSO in phosphate buffer and α-glucosidase enzyme,C is the absorbance of sample reaction containing sample solution and α-glucosidase enzyme,D is the absorbance of control sample containing only sample solution.

The concentration of samples that inhibited α-glucosidase activity by 50% was defined as the IC~50~ value.

5.6. In vitro studies in 3T3-L1 embryonic cells and L6 myoblast cells {#sec5.6}
---------------------------------------------------------------------

### 5.6.1. Cell culture {#sec5.6.1}

3T3-L1 cells were maintained in high-glucose Dulbecco\'s modified Eagle medium (DMEM) (Thermo Fisher Scientific, USA) supplemented with 10% (v/v) of fetal bovine serum (FBS) (Thermo Fisher Scientific, USA), 2 mM glutamine (Sigma Chemical, USA), streptomycin (Sigma Chemical, USA) (1%), penicillin (Sigma Chemical, USA) (1%), and high glucose concentration (4.5 g/L) at 37 °C in a 5% CO~2~ incubator. Cells at full confluence on the cell culture flask were subcultured and collected for cytotoxicity test \[3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay\] and glucose consumption assay.

L6 myoblast cells were incubated at 5% CO~2~ and 37 °C in high-glucose DMEM containing 10% (v/v) FBS, penicillin, and streptomycin. For glucose uptake assay, the cells were seeded in 24-well plates at a density of 2 × 10^4^ cells/mL. After 48 h, the medium was replaced with high-glucose DMEM containing 2% (v/v) FBS, which was replaced with new medium after 2, 4, and 6 days of culture ([@bib5]).

### 5.6.2. Glucose consumption assay {#sec5.6.2}

The procedure of the glucose consumption assay has been described in a previous study ([@bib39]; [@bib40]). A solution including 0.25% trypsin and 1 mM EDTA was used to detach 3T3-L1 cells from the culture flask, and complete culture medium was used to stop trypsin digestion. The cells were washed with phosphate buffer (pH 6.7) for twice and resuspended in low glucose (1.0 mg/mL) detection medium supplemented with 0.05% pluronic F68, 0.2% bactopeptone, and 2 mM glutamine. Next, 100 μL of 3T3-L1 cells (at a density of 1 × 10^5^ mL) were pipetted onto 96-well plates and cultured with various concentration of samples, insulin, or the standard drug metformin (final concentration 0--125 nM) at 37 °C in a 5% CO~2~ incubator for 4--48 h. After incubation, 10 μL of suspension from each well was transferred to another 96-well plate. The remaining glucose concentration in the suspension was evaluated after 30 min by illuminated reaction, and absorbance was measured at a wavelength 495 nm. Then, glucose concentration in the medium was calculated using a standard curve for glucose. Percent of glucose consumption was calculated according to the following formula, and IC~50~ value was evaluated.where,A is glucose concentration in the medium of the control group,B is glucose concentration in the medium of the treatment groupsC is the blank control (the same medium as that of the control group, but without cells)

### 5.6.3. Glucose uptake assaya {#sec5.6.3}

The time-dependent response of L6 myotubes to crude samples was examined following a previously described method ([@bib30]) with modification. Cells were incubated with samples and metformin for 24 h, washed twice with Kreb-Ringer bicarbonate buffer, incubated with Kreb-Ringer bicarbonate buffer for 1 h, and then starved in serum-free phosphate buffer saline containing 0.2% Bovine serum albumin for 1 h. After that, the cells were further incubated with 2-deoxy-2-\[(7-nitro-2, 1, 3-benzoxadiazol-4-yl) amino\]-D-glucose for 20 min. Fluorescence intensity was measured at excitation/emission wavelengths of 485/530 nm.

### 5.6.4. Cytotoxicity analysis (MTT assay) {#sec5.6.4}

3T3-L1 cells were cultured at a density of 1 × 10^4^ cells in 96-well plates with insulin (30 nM) in detection medium for 24--48 h at 37 °C in a 5% CO~2~ incubator. The cells were then subjected to MTT assay ([@bib12]) to evaluate the toxicity of the compounds to cells. Briefly, cells were treated with various doses (0.01--1000 μg/mL) of samples for 72 h at 37 °C in a 5% CO~2~ incubator, strained by addition of 100 μL MTT solution (0.5 mg/mL in phosphate buffer), and then further incubated for 4 h. After that, the suspension was collected and 150 μL of DMSO was added to each well. Absorbance was measured at 570 nm with a microplate reader. Percentage of cell viability was also determined.

### 5.6.5. Calculation {#sec5.6.5}

All data were expressed as the mean of triplicate experiments ±standard deviation. Dose-response curves were plotted using the percentages of α-glucosidase inhibition or glucose consumption and concentration (μg/mL). The concentration of treatment that inhibited α-glucosidase enzyme or promoted glucose consumption by 50% (IC~50~) were determined from regression analysis using Microsoft Excel (Microsoft Corporation, USA) and Graph Pad Prism version 6 (Graphpad Software Inc., USA).
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[^1]: Inactive at \> 100 μM.
